Standout Papers

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor... 2004 2026 2011 2018 774
  1. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo (2004)
    Elizabeth A. Harrington, David Bebbington et al. Nature Medicine

Immediate Impact

6 by Nobel laureates 21 from Science/Nature 59 standout
Sub-graph 1 of 21

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Phosphorylation and chromatin tethering prevent cGAS activation during mitosis
2021 StandoutScience
2 intermediate papers

Works of David Bebbington being referenced

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
2004 Standout

Author Peers

Author Last Decade Papers Cites
David Bebbington 124 508 409 546 8 912
Anita Diu‐Hercend 43 710 440 578 10 1.1k
Madeleine C. Brady 50 562 197 253 14 926
Nicole M. English 212 669 134 561 11 1.1k
Marilyn L. Keeler 30 837 200 282 7 1.1k
Felix Oppermann 28 893 174 334 16 1.1k
Teresa A. McCormack 86 731 289 116 10 992
Timothy C. Gahman 56 737 168 401 14 961
Steven M. Riddle 68 844 253 142 18 1.1k
Kenneth R. LaMontagne 54 742 269 148 21 1.0k
Donna Carr 123 722 393 119 17 987

All Works

Loading papers...

Rankless by CCL
2026